Medical Device | April 01, 2024
MTD acquires Ypsomed's pen needle and BGM businesses
This acquisition enables MTD to open new, strategic markets
This acquisition enables MTD to open new, strategic markets
If approved, enfortumab vedotin with KEYTRUDA would be the first combination in China to offer an alternative to chemotherapy
First and only AKT inhibitor approved in Japan for breast cancer patients with specific biomarker alterations
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Cipla completes transfer of Generics Business Undertaking
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
Subscribe To Our Newsletter & Stay Updated
